TP53 and breast carcinoma: Cdk4, for example, along with Cdk2, has been reported to play a role in the regulation of centrosome amplification, where knocking out Cdk4 and Cdk2 was found to restore the normal centrosome phenotype in p53 null cells [41] and breast cancer cells [45].